抑制剂:
β-defensin 40, ATP10A, ATP11A, ATP11B, ATP13A3, ATP1AL1, ATP1B3, ATP8B (P-type ATPases), ATP8B5, BC048609, C8orf5, CASPR4, CAT-4, cyclin M1, DDX41, Digoxigenin, Dok-2, E030010A14Rik, EG625716, FSH, FXYD7, GATA-4, Gm14139, Gm14306, Gm364, H1T2, HCN3, HIF-1 alpha, HIF-3α, hnRNP H′/hnRNP H2, HoxA13, IFN-α9, IL-17, Il-28a, LOXL4, MALAT-1, MFSD6L, Mmgt2, MYH15, Na+ CP type Iβ, Na+ CP type VIIα, Na+/K+ ATPase β4, Na+/K+-ATPase α1, Na+/K+-ATPase α4, Na+/K+-ATPase β1, Na+/K+-ATPase β2, Na+/K+-ATPase β3, NCKX2, NCKX4, Neurophysin I, NKAIN1, NKAIN2, NKAIN3, OATP-A, OATP-B, OATP1, Oatp3, Olfr824, Olfr988, Olr1413, Olr222, Olr252, Olr420, phospholemman, PQLC2, RORα, SFRS15, SLC10A4, SLC10A6, SLC10A7, SLC22A23, SLC24A1, SLC38A11, SLC38A6, SLC5A12, sodium/potassium-ATPase α1, sodium/potassium-ATPase α3, sodium/potassium-ATPase β1, sorcin, taperin, TMEM16K, TMEM38B, TR4, Troponin I-C, VDR, VPS51, 和 ZNF35.